WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $851,309 | -29.8% | 397,808 | 0.0% | 0.01% | -33.3% |
| Q2 2023 | $1,213,314 | +17.3% | 397,808 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,034,301 | +144.7% | 397,808 | +92.9% | 0.01% | +125.0% |
| Q4 2022 | $422,712 | -54.5% | 206,201 | 0.0% | 0.00% | -63.6% |
| Q3 2022 | $930,000 | +10.3% | 206,201 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $843,000 | -7.1% | 206,201 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $907,000 | -63.1% | 206,201 | 0.0% | 0.01% | -64.3% |
| Q4 2021 | $2,456,000 | -30.6% | 206,201 | 0.0% | 0.03% | -36.4% |
| Q3 2021 | $3,538,000 | -1.6% | 206,201 | 0.0% | 0.04% | +4.8% |
| Q2 2021 | $3,596,000 | – | 206,201 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
| MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
| Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
| RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
| Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
| Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
| PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |